Literature DB >> 2346805

Reversible cardiomyopathy induced by interferon.

M Sonnenblick1, D Rosenmann, A Rosin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2346805      PMCID： PMC1662916          DOI： 10.1136/bmj.300.6733.1174

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.

Authors:  L R Deyton; R E Walker; J A Kovacs; B Herpin; M Parker; H Masur; A S Fauci; H C Lane
Journal:  N Engl J Med       Date:  1989-11-02       Impact factor: 91.245

2.  Recombinant alpha 2 interferon-related cardiomyopathy.

Authors:  M C Cohen; M S Huberman; R W Nesto
Journal:  Am J Med       Date:  1988-10       Impact factor: 4.965

3.  Deaths halt interferon trials in France.

Authors:  D Dickson
Journal:  Science       Date:  1982-11-19       Impact factor: 47.728

4.  Alpha interferon for induction of remission in hairy-cell leukemia.

Authors:  J R Quesada; J Reuben; J T Manning; E M Hersh; J U Gutterman
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245
  4 in total
  11 in total

1.  Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.

Authors:  M Mirić; J Vasiljević; M Bojić; Z Popović; N Keserović; M Pesić
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

2.  Reversible cardiomyopathy in a patient with hairy cell leukaemia.

Authors:  G T Sucak; R Haznedar; R Yalçin
Journal:  Postgrad Med J       Date:  1998-05       Impact factor: 2.401

3.  Interferon-associated left ventricular dysfunction in a liver transplant recipient.

Authors:  R Mateo; S Jethmalani; D C Angus; J Gorcsan; B Uretsky; J Fung
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 4.  Mechanisms in acute septic cardiomyopathy: evidence from isolated myocytes.

Authors:  K Werdan; U Müller; C Reithmann; A Pfeifer; S Hallström; B Koidl; G Schlag
Journal:  Basic Res Cardiol       Date:  1991 Sep-Oct       Impact factor: 17.165

Review 5.  Heart failure induced by non-cardiac drugs.

Authors:  Lars Slørdal; Olav Spigset
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Interferon regulatory factors in heart: stress response beyond inflammation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190

Review 7.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

Review 8.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 9.  Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.

Authors:  Alan H Baik; Olalekan O Oluwole; Douglas B Johnson; Nina Shah; Joe-Elie Salem; Katy K Tsai; Javid J Moslehi
Journal:  Circ Res       Date:  2021-05-03       Impact factor: 23.213

10.  Role of imaging in the detection of reversible cardiomyopathy.

Authors:  Jae-Hyeong Park; Deborah H Kwon; Randall C Starling; Thomas H Marwick
Journal:  J Cardiovasc Ultrasound       Date:  2013-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.